These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31887202)

  • 1. Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome.
    Jehle J; Goerich H; Bindila L; Lutz B; Nickenig G; Tiyerili V
    PLoS One; 2019; 14(12):e0227142. PubMed ID: 31887202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Microvesicles Circulating in Peripheral and Coronary Circulation Are Associated With Central Blood Pressure in Coronary Artery Disease.
    Gkaliagkousi E; Gavriilaki E; Vasileiadis I; Nikolaidou B; Yiannaki E; Lazaridis A; Triantafyllou A; Anyfanti P; Markala D; Zarifis I; Douma S
    Am J Hypertens; 2019 Nov; 32(12):1199-1205. PubMed ID: 31350539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Plaque Rupture in Stable Coronary Artery Disease and Non-ST Segment Elevation Myocardial Infarction: An Optical Coherence Tomography Study.
    Mariani L; Burzotta F; Aurigemma C; Scalone G; Fracassi F; Niccoli G; Vergallo R; Romano A; Aimi A; Di Vito L; Silenzi S; Grossi P; Trani C; Crea F
    J Invasive Cardiol; 2021 Nov; 33(11):E843-E850. PubMed ID: 34619657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
    Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
    Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Mean Platelet Volume to Predict Significant Coronary Artery Disease in Patients With Non-ST-Elevation Acute Coronary Syndromes.
    Taskesen T; Sekhon H; Wroblewski I; Goldfarb M; Ahmad MB; Nguyen QT; Fughhi IA; Gidron A; Dadkhah S
    Am J Cardiol; 2017 Jan; 119(2):192-196. PubMed ID: 27814786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.
    Jehle J; Schöne B; Bagheri S; Avraamidou E; Danisch M; Frank I; Pfeifer P; Bindila L; Lutz B; Lütjohann D; Zimmer A; Nickenig G
    PLoS One; 2018; 13(5):e0197751. PubMed ID: 29813086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in T/QRS ratio can be a supplementary diagnostic tool in predicting coronary artery disease in patients with NSTEMI.
    Choi Y; Lee JH; Seo JI
    Am J Emerg Med; 2021 Jan; 39():48-54. PubMed ID: 31954545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):1217-1234. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
    Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
    van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
    Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes.
    Damen SAJ; Cramer GE; Dieker HJ; Gehlmann H; Aengevaeren WRM; Oude Ophuis TJM; Fokkert MJ; Dikkeschei LD; Vroemen WHM; Verheugt FWA; Brouwer MA; Suryapranata H
    Atherosclerosis; 2018 Nov; 278():117-123. PubMed ID: 30268067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal artery intervention for a patient with flash pulmonary edema accompanied by elevation of troponin levels due to bilateral renal artery stenosis and multivessel coronary disease: a case report.
    Sun R; Li B; Chen X; Chen Y; Li L
    J Int Med Res; 2020 Jun; 48(6):300060520926032. PubMed ID: 32495661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair.
    Jehle J; Eich L; Danisch M; Bagheri S; Avraamidou E; Pfeifer P; Tiyerili V; Bindila L; Lutz B; Nickenig G
    Int J Cardiol; 2021 Jan; 323():243-250. PubMed ID: 32810540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    Altamura C; Ventriglia M; Martini MG; Montesano D; Errante Y; Piscitelli F; Scrascia F; Quattrocchi C; Palazzo P; Seccia S; Vernieri F; Di Marzo V
    J Alzheimers Dis; 2015; 46(2):497-506. PubMed ID: 25818503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
    Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH
    Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and in-hospital outcome of patients with no ST-segment elevation acute coronary syndrome and no obstructive coronary artery disease in the era of high-sensitivity troponins.
    Lanza GA; Melita V; Mencarelli E; De Vita A; Bisignani A; Manfredonia L; Covino M; Crea F
    J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):210-214. PubMed ID: 30720634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.